4//SEC Filing
MORTIMER IAN 4
Accession 0001193125-25-313147
CIK 0001582313other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 7:40 PM ET
Size
10.1 KB
Accession
0001193125-25-313147
Insider Transaction Report
Form 4
MORTIMER IAN
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Shares
2025-12-05$45.03/sh−14,375$647,306→ 16,830 total - Sale
Common Shares
2025-12-08$45.59/sh−8,820$402,104→ 8,010 total - Sale
Common Shares
2025-12-08$46.32/sh−2,010$93,103→ 6,000 total
Holdings
- 14,300(indirect: By Spouse)
Common Shares
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.00 to $45.135, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.02 to $46.013, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.02 to $46.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001619961
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 7:40 PM ET
- Size
- 10.1 KB